Letter to the Editor

Case of Reverse Takotsubo Cardiomyopathy in Status Asthmaticus

Authors: Dusan A. Stanojevic, MD, Venkata M. Alla, MBBS, MD, Joseph D. Lynch, MD, Claire B. Hunter, MD

Abstract

To the Editor:


We read with interest the paper on stress cardiomyopathy (SC) following use of ketamine and epinephrine by Osuorji et al1 in the March 2009 issue of the Southern Medical Journal. In this context, we would like to bring to the readers' attention a somewhat similar observation we made.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Osuorji I, Williams C, Hessney J, et al. Acute stress cardiomyopathy following treatment of status asthmaticus. South Med J 2009;102:301–303.
 
2. Akashi YJ, Goldstein DS, Barbaro G, et al. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. [Review]. Circulation 2008;118:2754–2762.
 
3. Lee YP, Poh KK, Lee CH, et al. Diverse clinical spectrum of stress-induced cardiomyopathy. Int J Cardiol 2009;133:272–275.
 
4. Cazzola M, Matera MG, Donner CF. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs 2005;65:1595–1610.
 
5. Vittone L, Said M, Mattiazzi A. Beta 2-adrenergic stimulation is involved in the contractile dysfunction of the stunned heart. Naunyn Schmiedebergs Arch Pharmacol 2006;373:60–70.